Austin, TX (PRWEB) August 20, 2013
Albert Einstein College of Medicine of Yeshiva University and Vindico Medical Education are pleased to announce their upcoming continuing medical education (CME) meeting titled: “HCV VOICE: Optimizing Virological Outcomes with Integrated HCV Education.” Gastroenterologists, hepatologists, infectious disease specialists, as well as nurse practitioners, physician assistants, and other health care professionals involved in the diagnosis and active management of patients with HCV are invited to attend this live CME meeting.
Chronic hepatitis C virus (HCV) infection is a leading cause of cirrhosis, end-stage liver disease, hepatocellular carcinoma, and death from liver disease in the United States. Effective management of HCV continues to pose a challenge for health care practitioners. The purpose of this unique HCV VOICE initiative is to provide specific, targeted educational opportunities for clinicians who are involved in the management of patients with HCV. The continuing medical education faculty aims to incorporate a case-based approach to present the most current data on the following topics:
1. Evaluating Current and Near-term Treatment Options: Selecting the Right Regimen for Your Patient Now
2. Future Therapies: Understanding Emerging IFN-free Options
Upon completion of Topic 1, participants should be better able to:
- Evaluate HCV patients on direct-acting antiviral agent (DAA) therapy for potential adverse events, drug interactions, and issues relating to drug adherence and appropriately address to optimize outcomes
- Evaluate evidence-based medicine and clinical data pertaining to when and how to select HCV treatment in order to individualize care and improve patient health and outcomes
- Integrate in to clinical practice the most recent data about the safety and efficacy of HCV treatment regimens to assist in current and near-term clinical decision-making
Upon completion of Topic 2, participants should be better able to:
- Evaluate evidence-based medicine and clinical data pertaining to when and how to select HCV treatment in order to individualize care and improve patient health and outcomes
- Integrate into clinical practice the most recent data about the safety and efficacy of HCV treatment regimens to assist in current and near-term clinical decision-making
- Evaluate the use of interferon-based versus interferon-free regimens for the treatment of HCV
For more information about this CME meeting and to register, please visit:
Online at http://www.hcvvoice.com
Call us toll-free at 800-897-3185
Twitter @ HCV_CME
Tumblr @ HCV-CME
Accreditation
Albert Einstein College of Medicine of Yeshiva University is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation
Albert Einstein College of Medicine of Yeshiva University designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This continuing medical education activity is co-sponsored by Albert Einstein College of Medicine of Yeshiva University and Vindico Medical Education.
This activity is supported by educational grants from AbbVie and Genentech.
About Albert Einstein College of Medicine of Yeshiva University
Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center, the University Hospital for the Albert Einstein College of Medicine, Einstein Montefiore Center for Continuing Medical Education has been actively engaged in producing CME programs for the past 37 years. CME is an integral part of our overriding educational mission. Albert Einstein College of Medicine and Montefiore Medical Center is committed to the utilization of resources for advancement of all three stages of medical education: undergraduate doctoral degree studies; postgraduate residency and specialty training; and continuing medical education manifesting itself throughout the physicians professional career.
Albert Einstein College of Medicine is a prestigious academic institution well recognized, with the largest residency training program in the country. Montefiore Medical Center (Montefiore) trains more than 900 residents in 14 specialties annually. Montefiore has 1500 beds on three campuses in use and is the leading provider of acute, ambulatory, and preventive care in the Bronx.
Because of the development of new techniques and treatment strategies, the College of Medicine recognizes the vital importance of Continuing Medical Education to professional competence and reaffirms its responsibility, as a major academic medical center, to contribute to patient care through the support and advancement of CME.
The Einstein Montefiore Center for Continuing Medical Education has produced hundreds of CME print supplements and has offered CME credit to thousands of practitioners. Every year, in addition to our CyberoundsÒ eCME activities, we conduct more than 200 meetings at national, regional and local gatherings of clinicians including annual meetings of major specialty organizations.
About Vindico Medical Education
Vindico Medical Education is solely dedicated to delivering the highest quality and immediately relevant educational programs. These activities provide health care professionals with information on clinical advances they need to better treat their patients.
Vindico delivers the highest quality and relevant educational programs and activities to physicians and other health care providers, with the ultimate goal of improving patient health. With delivery through the more than 30 specialty journals and newspapers published by its sister company, SLACK Incorporated, Vindico Medical Education has access to more than 300,000 physicians, nurses and other health care professionals every month, and long-standing relationships with key opinion leaders worldwide.
Vindico employs an experienced team of medical writers and editors, dedicated meeting managers, plus in-house design and marketing departments, ensuring a seamless process from project development through delivery.
Release issued by Audience Generation, LLC
Audience Generation is a forward-thinking agency at the forefront of the digital revolution and is a nationally and internationally recognized provider of integrated marketing, advertising, and technology services and solutions that offer a new way to find, generate, and engage live, online, social, and mobile audiences where they exist on demand.
Audience Generation is known for its creative strategy, actionable solutions and measurable approach to transforming the ways brands interact with their target audience, whether they exist in person, online, via social networks, or on their mobile devices.
Audience Generation has produced winning traditional, online, e-commerce, social and mobile campaigns including mobile application solutions for Fortune 500, small and medium businesses, not-for-profit organizations, national and international associations and societies, and venture-backed start-up companies across a variety of industry verticals around the world.
To learn how Audience Generation can find your ideal customer, reach them where they exist, build your brand, and grow your bottom line, please call us at 512-708-4678 or email us at growyourbusiness(at)audiencegeneration(dot)com or visit us at http://www.audiencegeneration.com.